Tradestie Institutional Equity Comparison Engine

PLSE vs DXR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PLSE Overall Edge

PLSE Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pulse Biosciences, Inc Common Stock (DE) (PLSE) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while DXR counters with relative strength in Valuation. Fundamentally, PLSE trades at N/M Forward P/E with -5861.2% operating margin (+359.3% YoY revenue) versus DXR at 64.5x Forward P/E and -5894.3% operating margin (+25.5% YoY). In options structure, PLSE sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro) against DXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner DXR
PLSE N/M vs DXR 64.5x Fwd P/E
Growth & Margin Winner PLSE
Op Margin -5861.2% vs -5894.3% ยท YoY +359.3% vs +25.5%
Momentum & Technical Winner PLSE
1Y +227.9% vs -38.3% ยท 52W Pos 73% vs 2%
Options & Structure Winner PLSE
CONSOLIDATION (10th %ile IV) vs UNCLASSIFIED (N/A IV)
PLSE NASDAQ
Pulse Biosciences, Inc Common Stock (DE)
Surgical & Medical Instruments & Apparatus
$46.36
-8.09% 1D
Market Cap $3.7B
1M Return +4.34%
1Y Return +227.86%
Forward P/E N/M
Unified AI Score
40.1 / 100 SELL
Tech 25.0 Fund 46.0 Flow 70.0 Mom 50.0
DXR NASDAQ
Daxor Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$8.36
-1.47% 1D
Market Cap $49.5M
1M Return -16.87%
1Y Return -38.29%
Forward P/E 64.5x
Unified AI Score
52.2 / 100 HOLD
Tech 52.0 Fund 59.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PLSE +227.86% DXR -38.29% Spread: +261.13 pp (PLSE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PLSE TTM Op. Margin: -5861.2% DXR TTM Op. Margin: -5894.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PLSE vs DXR. Trailing 12-month operating profitability (PLSE -5861.2% vs DXR -5894.3%) and valuation multiples (PLSE N/M vs DXR 64.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PLSE (4) vs DXR (6)
Institutional Metric PLSE DXR Criterion Row Winner
Market Capitalization Scale $3.7B $49.5M Larger Scale PLSE
Trailing P/E Ratio Valuation N/M 7.7x Lower Multiple DXR
Forward P/E Ratio Valuation N/M 64.5x Lower Multiple DXR
Revenue Growth (YoY) Growth +359.3% +25.5% Higher Growth PLSE
Operating Margin (TTM) Profitability -5861.2% -5894.3% Higher Margin PLSE
Net Profit Margin Profitability 0.0% 19861.4% Higher Margin DXR
Return on Equity (ROE) Capital Efficiency -60.6% 14.2% Higher ROE DXR
52-Week Range Position Momentum 73% ($13โ€“$59) 2% ($8โ€“$15) Stronger Trend PLSE
Beta / 30D Volatility Risk Regime 1.71ฮฒ ยท 78% Vol 0.28ฮฒ ยท 32% Vol Lower Realized Risk DXR
Unified Institutional Score Composite Signal 40.1 / 100 (SELL) 52.2 / 100 (HOLD) Higher Composite DXR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PLSE vs DXR Buy Guide
PLSE CONSOLIDATION
51d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live PLSE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DXR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DXR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PLSE nor DXR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.